| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
8,176 |
6,864 |
$354K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,822 |
3,974 |
$165K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,648 |
1,363 |
$108K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,190 |
1,011 |
$48K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
821 |
688 |
$44K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
432 |
346 |
$23K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,151 |
911 |
$22K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
450 |
415 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,381 |
616 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
431 |
354 |
$4K |
| 81002 |
|
430 |
353 |
$788.57 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12 |
12 |
$145.05 |